Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Mta3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MTA3 mRNA | CTD | PMID:36331819 | 17beta-estradiol | increases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of MTA3 protein | CTD | PMID:15955695 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Mta3 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mta3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MTA3 mRNA | CTD | PMID:24058054 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of MTA3 mRNA | CTD | PMID:21346803 | aflatoxin B1 | decreases expression | ISO | Mta3 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of MTA3 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MTA3 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | affects methylation | ISO | MTA3 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of MTA3 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MTA3 mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of MTA3 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MTA3 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MTA3 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MTA3 gene | CTD | PMID:25304211 | atrazine | increases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of MTA3 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of MTA3 gene | CTD | PMID:35440735 | benzo[a]pyrene | increases expression | ISO | Mta3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MTA3 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of MTA3 protein | CTD | PMID:33278487 | benzo[a]pyrene | affects methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MTA3 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MTA3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MTA3 mRNA | CTD | PMID:26238291 | benzo[e]pyrene | increases methylation | ISO | MTA3 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of MTA3 intron | CTD | PMID:30157460 | bisphenol A | affects methylation | ISO | Mta3 (Mus musculus) | 6480464 | bisphenol A affects the methylation of MTA3 promoter | CTD | PMID:27334623 | bisphenol A | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MTA3 protein | CTD | PMID:37567409 | bisphenol A | decreases expression | ISO | Mta3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MTA3 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MTA3 mRNA | CTD | PMID:30816183 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of MTA3 promoter | CTD | PMID:22457795 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MTA3 mRNA | CTD | PMID:33453195 | caffeine | increases phosphorylation | ISO | MTA3 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of MTA3 protein | CTD | PMID:35688186 | carbamazepine | affects expression | ISO | MTA3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of MTA3 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Mta3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MTA3 gene] | CTD | PMID:28238834 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MTA3 mRNA | CTD | PMID:17602206 | coumarin | increases phosphorylation | ISO | MTA3 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of MTA3 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MTA3 mRNA | CTD | PMID:25562108 | deoxynivalenol | affects phosphorylation | ISO | Mta3 (Mus musculus) | 6480464 | deoxynivalenol affects the phosphorylation of MTA3 protein | CTD | PMID:23352502 | diquat | increases expression | ISO | Mta3 (Mus musculus) | 6480464 | Diquat results in increased expression of MTA3 protein | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of MTA3 mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MTA3 mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Mta3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MTA3 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of MTA3 mRNA | CTD | PMID:27664576 | FR900359 | affects phosphorylation | ISO | MTA3 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of MTA3 protein | CTD | PMID:37730182 | hexadecanoic acid | increases phosphorylation | ISO | MTA3 (Homo sapiens) | 6480464 | Palmitic Acid results in increased phosphorylation of MTA3 protein | CTD | PMID:28073184 | hydralazine | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MTA3 mRNA | CTD | PMID:17183730 | hydrogen peroxide | affects expression | ISO | MTA3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of MTA3 mRNA | CTD | PMID:20044591 | hypochlorous acid | decreases expression | ISO | Mta3 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of MTA3 mRNA | CTD | PMID:19376150 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of MTA3 mRNA | CTD | PMID:21396975 | ivermectin | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MTA3 protein | CTD | PMID:32959892 | melphalan | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of MTA3 mRNA | CTD | PMID:22363485 | methapyrilene | increases methylation | ISO | MTA3 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of MTA3 intron | CTD | PMID:30157460 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of MTA3 mRNA | CTD | PMID:30467583 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of MTA3 gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of MTA3 mRNA | CTD | PMID:28001369 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MTA3 mRNA | CTD | PMID:17602206 | paracetamol | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MTA3 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MTA3 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mta3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MTA3 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of MTA3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTA3 mRNA | CTD | PMID:27188386 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of MTA3 mRNA | CTD | PMID:19013527 | SB 431542 | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | trichostatin A | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of MTA3 mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | MTA3 (Homo sapiens) | 6480464 | trichostatin A affects the expression of MTA3 mRNA | CTD | PMID:28542535 | valproic acid | multiple interactions | ISO | MTA3 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MTA3 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | valproic acid | affects expression | ISO | Mta3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of MTA3 mRNA | CTD | PMID:17292431 and PMID:17963808 | valproic acid | affects expression | ISO | MTA3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MTA3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MTA3 mRNA | CTD | PMID:23179753 more ... | vincristine | decreases expression | ISO | MTA3 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of MTA3 mRNA | CTD | PMID:23649840 | |